Live Breaking News & Updates on Translational Officer
Stay updated with breaking news from Translational officer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Updated data from azenosertib monotherapy study with longer follow up shows 37% ORR and mPFS of 6.5 months in heavily pretreated ovarian and uterine serous carcinoma patients Azenosertib programs on. ....
Washington, DC (PRWEB) April 10, 2023 The Society for RNA Therapeutics is pleased to announce the members of its charter board of directors. The mission of ....